Učitavanje...
R-CHOP without Radiation in Frontline Management of Primary Mediastinal B-cell Lymphoma
Prior to the introduction of rituximab, primary mediastinal B-cell lymphoma (PMBCL) had high rates of treatment failure with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), prompting the use of consolidative mediastinal radiation or more intensive chemotherapy regimens. Cure rates...
Spremljeno u:
| Izdano u: | Leuk Lymphoma |
|---|---|
| Glavni autori: | , , , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6472975/ https://ncbi.nlm.nih.gov/pubmed/30656983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2018.1519812 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|